Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.80
Bid: 8.70
Ask: 8.90
Change: 0.12 (1.38%)
Spread: 0.20 (2.299%)
Open: 8.55
High: 8.80
Low: 8.68
Prev. Close: 8.68
ANIC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment of US$3million in Foods United

12 Feb 2020 07:00

RNS Number : 6864C
Agronomics Limited
12 February 2020
 

12 February 2020

 

Agronomics Limited

 

("Agronomics" or the "Company")

 

Agronomics Announces Participation of USD 3 Million in Foods United raise of up to USD 100 Million

 

The Board of Agronomics is pleased to announce it has today completed a subscription of US $3,000,000 Class B Shares (the "Subscription") in Foods United, Inc ("Foods United"). This will be paid using cash from the Company's own resources, following its recent successful fundraise of £5.5 million on 24th January 2020. The Subscription will give Agronomics an approximate 3% equity interest in Foods United should they raise the full targeted amount of US$100million.

 

Foods United is a Delaware Company, with offices located in the US and Switzerland, and is focused on leveraging traditional industry partners with existing logistics and infrastructure for fast and efficient scaling of meat replacement food products, initially focusing on plant-based chicken. Foods United team includes Kees Kruythoff, President and Aldo Uva, Chief Innovation Officer, both of whom are veterans of the food industry with extensive experience at major food companies including Ferrero Corporation, Unilever PLC, Nestle SA, and Firmenich SA. The team will work with early-stage alternative protein companies, helping them to achieve scale globally, through vertical integration and strategic partnerships throughout the supply chain.

 

Foods United was founded by Roger Lienhard's Blue Horizon Corporation ("Blue Horizon"), a major early player in the alternative protein sector with an established portfolio of 39 seed investments. Blue Horizon also manages a venture capital fund with assets under management of EUR 100 million and the Blue Horizon International Foundation. This early focus on removing animals from the global food supply chain has given Blue Horizon a unique perspective into the future of food.

 

As the Subscription is considered a Substantial Transaction under AIM rules, this announcement requires certain disclosures under Schedule Four of the AIM Rules. Foods United is a start-up company with cash burn rate of approximately US$265,000 per month and net assets as at 30 November 2019 of approximately US$37 million, including gross cash proceeds received as part of the US$100million target raise of approximately US$38.6million.

 

Richard Reed, Chairman of Agronomics, commented on the Subscription: -

 

"Blue Horizon has been at the forefront of the alternative protein movement and with the formation of Foods United, they have once again demonstrated its leadership position. We are thrilled to have been given the opportunity to participate in Foods United's seed round. We look forward to working more closely with Roger and Blue Horizon."

 

Roger Lienhard, Chairman of Blue Horizon added: -

 

"We are particularly excited to have extended our investor group within this founder round to investors like Agronomics. We need people exactly like the team at Agronomics to be able to grasp the absolute need as well the opportunity to foster and accelerate the transformation of the food industry. Our concept of working with the incumbents being the traditional meat industry helps us to change the world faster - in order to offer tasty, healthy and sustainable food for everyone."

 

About Agronomics

 

Agronomics is an AIM-listed investment company focused on the nascent field of cellular agriculture and synthetic biology, with an emphasis on environmentally friendly alternatives to the traditional production of animal-derived products. The Company was launched in April 2019, with the appointment of a highly experienced team of investors and entrepreneurs including Richard Reed, Jim Mellon and David Giampaolo.

Agronomics believes that the recent developments within cellular agriculture and the alternative protein space will play a major role in feeding the world's growing population as it approaches 10 billion people by 2050. The production of animal protein via novel approaches is a viable solution to minimise global greenhouse gas emissions, water, energy and land requirements as well as alleviating animal welfare concerns.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ('MAR'). Upon the publication of this announcement via a Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain. 

For further information, please contact:

Agronomics Limited

Beaumont Cornish Limited

 

Zeus Capital Limited

Peterhouse Capital Limited

The Company

 

Nomad

Joint Broker

Joint Broker

Richard Reed

Denham Eke

 

Roland Cornish

James Biddle

 

Rupert Woolfenden

Emma Ayton

Lucy Williams

Charles Goodfellow

 

+44 (0) 1624 639396

+44 (0) 207 628 3396

+44 (0) 20 3829 5000

+44 (0) 207 469 0936

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAXAFFLDEEFA
Date   Source Headline
23rd Dec 201612:00 pmRNSFinal Results and Notice of AGM
22nd Dec 20162:41 pmRNSLoan to the Diabetic Boot Company Ltd
12th Oct 20167:00 amRNSNet Asset Value(s)
22nd Jul 20167:00 amRNSNet Asset Value(s)
29th Apr 20167:00 amRNSNet Asset Value calculation to 31 March 2016
15th Apr 20167:00 amRNSChange of Adviser
18th Mar 20167:00 amRNSHolding(s) in Company
17th Mar 20167:00 amRNSInterim Results for the six months to 31 Dec 2015
10th Feb 201612:11 pmRNSResult of AGM
25th Jan 20167:00 amRNSNet Asset Value(s)
22nd Dec 20157:00 amRNSAnnual Audited Results and Notice of AGM
17th Dec 20154:00 pmRNSDBC receives US FDA approval to market PulseFlowDF
4th Nov 20157:00 amRNSNet Asset Value(s)
30th Jul 20157:01 amRNSNet Asset Value(s)
15th Apr 20157:00 amRNSNet Asset Value as at 31 March 2015
30th Mar 20157:00 amRNSInterim results for 6 months to 31 December 2014
6th Feb 201512:21 pmRNSClose of Tender Offer
4th Feb 20155:36 pmRNSRe Results of Tender Offer
2nd Feb 20158:00 amRNSResults of Tender Offer
23rd Jan 20157:00 amRNSHolding(s) in Company
15th Jan 201511:56 amRNSHolding(s) in Company
14th Jan 20157:00 amRNSTender Offer
12th Jan 20159:32 amRNSNet Asset Value
30th Dec 20147:00 amRNSAnnual audited results
23rd Dec 201411:58 amRNSHolding(s) in Company
28th Nov 20142:04 pmRNSTender Offer in respect of Magna Biopharma
21st Oct 20147:00 amRNSNet Asset Value to 30 September 2014
22nd Jul 20147:00 amRNSNet Asset Value(s)
8th Apr 20147:00 amRNSNet Asset Value calculations to 31 March 2014
31st Mar 20147:00 amRNSInterim Results for the six months to 31 Dec 2013
24th Jan 201411:21 amRNSHolding(s) in Company
20th Jan 201410:56 amRNSHolding(s) in Company
17th Jan 20147:00 amRNSNet Asset Value(s)
15th Jan 20147:00 amRNSAppointment of Nominated Adviser
6th Jan 20145:49 pmRNSHolding(s) in Company
20th Nov 20134:04 pmRNSHolding(s) in Company
13th Nov 20135:13 pmRNSHolding(s) in Company
12th Nov 20137:00 amRNSResult of General Meeting
24th Oct 20137:01 amRNSNotice of General Meeting
24th Oct 20137:00 amRNSAnnual Financial Report
18th Oct 201311:23 amRNSHolding(s) in Company
18th Oct 20137:00 amRNSNet Asset Value(s)
4th Oct 20132:13 pmRNSHolding(s) in Company
26th Sep 20135:10 pmRNSHolding(s) in Company
13th Sep 201311:32 amRNSHolding(s) in Company
6th Sep 20135:29 pmRNSHolding(s) in Company
6th Aug 20139:40 amRNSHolding(s) in Company
11th Jul 20137:00 amRNSNet Asset Value(s)
15th Apr 201312:34 pmRNSDirectorate Change
12th Apr 20132:17 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.